FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313134644> ?p ?o ?g. }

• W2313134644 endingPage "86" @default.
• W2313134644 startingPage "81" @default.
• W2313134644 abstract "Objective: To describe the effects of performance-enhancing supplements and caffeine on the blood pressure (BP) of an adolescent male. Case Summary: An adolescent male presented to his primary care provider for a preseason athletic physical. On physical exam, his BP was 162/90, exceeding the 99th percentile for his age. It had been elevated during the previous 2 yearly physicals. He was referred to the Pediatric Preventive Cardiology Clinic for follow-up. Illegal substance use and renal trauma were ruled out. During the evaluation, the patient acknowledged using energy drinks and performance-enhancing supplements, the majority of which were caffeine-based. His intention was to continue the use of supplements, so lisinopril was initiated. On follow-up, however, the patient reported supplement discontinuation, intermittent medication adherence, and lower home-based BP readings. He was subsequently lost to follow-up. An objective causality assessment revealed that the adverse drug event was probable. Discussion: When working with adolescent patients, it is particularly important to conduct an in-depth interview reflecting lifestyle choices. Use of performance-enhancing supplements and caffeine for adolescent athletes has been well reported in the literature. Adolescent use of supplements may be driven by misguided beliefs and lack of knowledge about potentially detrimental health effects, such as altered heart rate and elevated BP. Little evidence-based research is available to provide treatment guidance for clinicians regarding potential effects. Conclusions: A thorough patient history, including specific questions probing for any recent or chronic use of nutritional supplements, including energy drinks, will help identify substances that may contribute to BP variations. Even mild BP elevations in adolescents should lead clinicians to further investigate supplement use and include specific questions on any product use within the past 24 hours, several days, or longer. Adolescents may not consider the potential for adverse health effects when ingesting performance-enhancing supplements or energy drinks." @default.
• W2313134644 created "2016-06-24" @default.
• W2313134644 creator A5005776773 @default.
• W2313134644 creator A5035577356 @default.
• W2313134644 creator A5073802278 @default.
• W2313134644 creator A5079734047 @default.
• W2313134644 date "2014-05-13" @default.
• W2313134644 modified "2023-09-27" @default.
• W2313134644 title "Hypertension in an Adolescent Secondary to Performance-Enhancement Supplement Use" @default.
• W2313134644 cites W148115219 @default.
• W2313134644 cites W1890111775 @default.
• W2313134644 cites W1964833004 @default.
• W2313134644 cites W1965452273 @default.
• W2313134644 cites W1979794826 @default.
• W2313134644 cites W2026966185 @default.
• W2313134644 cites W2037099066 @default.
• W2313134644 cites W2066617366 @default.
• W2313134644 cites W2066957040 @default.
• W2313134644 cites W2067978628 @default.
• W2313134644 cites W2071556120 @default.
• W2313134644 cites W2073766890 @default.
• W2313134644 cites W2091073732 @default.
• W2313134644 cites W2107157101 @default.
• W2313134644 cites W2112879571 @default.
• W2313134644 cites W2115397113 @default.
• W2313134644 cites W2120061101 @default.
• W2313134644 cites W2129265364 @default.
• W2313134644 cites W2131749953 @default.
• W2313134644 cites W2136192897 @default.
• W2313134644 cites W2139177663 @default.
• W2313134644 cites W2142669260 @default.
• W2313134644 cites W2143954917 @default.
• W2313134644 cites W2146665043 @default.
• W2313134644 cites W2151638043 @default.
• W2313134644 cites W2152946896 @default.
• W2313134644 cites W2162314755 @default.
• W2313134644 cites W2162934205 @default.
• W2313134644 cites W2165539717 @default.
• W2313134644 cites W2166882762 @default.
• W2313134644 cites W2319416888 @default.
• W2313134644 cites W2402246296 @default.
• W2313134644 cites W3165153188 @default.
• W2313134644 cites W4241672142 @default.
• W2313134644 cites W4246361818 @default.
• W2313134644 doi "https://doi.org/10.1177/8755122513503790" @default.
• W2313134644 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5990129" @default.
• W2313134644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34860875" @default.
• W2313134644 hasPublicationYear "2014" @default.
• W2313134644 type Work @default.
• W2313134644 sameAs 2313134644 @default.
• W2313134644 citedByCount "2" @default.
• W2313134644 countsByYear W23131346442021 @default.
• W2313134644 countsByYear W23131346442023 @default.
• W2313134644 crossrefType "journal-article" @default.
• W2313134644 hasAuthorship W2313134644A5005776773 @default.
• W2313134644 hasAuthorship W2313134644A5035577356 @default.
• W2313134644 hasAuthorship W2313134644A5073802278 @default.
• W2313134644 hasAuthorship W2313134644A5079734047 @default.
• W2313134644 hasBestOaLocation W23131346442 @default.
• W2313134644 hasConcept C126322002 @default.
• W2313134644 hasConcept C1862650 @default.
• W2313134644 hasConcept C187212893 @default.
• W2313134644 hasConcept C197934379 @default.
• W2313134644 hasConcept C27016395 @default.
• W2313134644 hasConcept C2777880890 @default.
• W2313134644 hasConcept C2778715236 @default.
• W2313134644 hasConcept C2781054738 @default.
• W2313134644 hasConcept C3020169349 @default.
• W2313134644 hasConcept C512399662 @default.
• W2313134644 hasConcept C71924100 @default.
• W2313134644 hasConcept C84393581 @default.
• W2313134644 hasConceptScore W2313134644C126322002 @default.
• W2313134644 hasConceptScore W2313134644C1862650 @default.
• W2313134644 hasConceptScore W2313134644C187212893 @default.
• W2313134644 hasConceptScore W2313134644C197934379 @default.
• W2313134644 hasConceptScore W2313134644C27016395 @default.
• W2313134644 hasConceptScore W2313134644C2777880890 @default.
• W2313134644 hasConceptScore W2313134644C2778715236 @default.
• W2313134644 hasConceptScore W2313134644C2781054738 @default.
• W2313134644 hasConceptScore W2313134644C3020169349 @default.
• W2313134644 hasConceptScore W2313134644C512399662 @default.
• W2313134644 hasConceptScore W2313134644C71924100 @default.
• W2313134644 hasConceptScore W2313134644C84393581 @default.
• W2313134644 hasIssue "3" @default.
• W2313134644 hasLocation W23131346441 @default.
• W2313134644 hasLocation W23131346442 @default.
• W2313134644 hasLocation W23131346443 @default.
• W2313134644 hasLocation W23131346444 @default.
• W2313134644 hasOpenAccess W2313134644 @default.
• W2313134644 hasPrimaryLocation W23131346441 @default.
• W2313134644 hasRelatedWork W2012800385 @default.
• W2313134644 hasRelatedWork W2073297710 @default.
• W2313134644 hasRelatedWork W2379983916 @default.
• W2313134644 hasRelatedWork W2466043692 @default.
• W2313134644 hasRelatedWork W2766844642 @default.
• W2313134644 hasRelatedWork W2792428998 @default.
• W2313134644 hasRelatedWork W2913598963 @default.
• W2313134644 hasRelatedWork W2936734228 @default.

• next